IndustryIntelligence | Biotechnology & Drugs

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$40	Subscribers Preview	2003	15-Day Extension for Form 10-K Filed by King Pharmaceuticals	King Pharmaceuticals Inc.
$39	Subscribers	2003	aaiPharma and Cima Announce Merger to Create a Leading Science-Based, Specialty Pharmaceutical Company	aaiPharma; Cima Labs	Faegre & Benson; Latham & Watkins
$34	Subscribers Preview	2003	Aastrom Biosciences, Inc. Reports Fourth Quarter Financial Results	Aastrom Biosciences, Inc.	Stanford University
$40	Subscribers Preview	2003	Aastrom Biosciences, Inc. Reports Third Quarter Financial Results	Aastrom Biosciences, Inc.
$40	Subscribers Preview	2002	Abaxis to Comply with Preliminary Injunction While Evaluating Its Legal Options	Abaxis, Inc.
$38	Subscribers Preview	2000	Abgenix and CuraGen to Develop Up to 250 Antibody Therapeutic Candidates	Abgenix, Inc.	CuraGen Corp.
$40	Subscribers Preview	2003	Able Laboratories Announces Acquisition of Liquisource, Inc.	Able Laboratories Inc.
$38	Subscribers Preview	2003	Abstract	Wiehle, Ronald Dennis	Zonagen, Inc.
$45	Subscribers Preview	2002	Access Agreement	ACLARA; Third Wave; Chase Manhattan	Latham & Watkins; WSGR
$39	Subscribers Preview	2001	Accommodation Agreement	Hunts Drive, LLC; Kauser Partners, L.P.	BioPulse
$35	Subscribers Preview	2003	Acknowledgment of Subordination	The John N. Kapoor Trust	Akorn, Inc.
$37	Subscribers	2004	Addendum	Vicuron Pharmaceuticals, Inc.
$33	Subscribers	2003	Addendum	Vicuron Pharmaceuticals, Inc.
$32	Subscribers	2003	Addendum	OXiGENE, Inc.
$38	Subscribers Preview	2002	Addendum	OXiGENE, Inc.
$31	Subscribers	2003	Additional Results Support Cancer Trials Strategy	Progen Industries Ltd.
$46	Subscribers Preview	2000	Administrative Services and Management Agreement	Introgen Therapeutics, Inc.	Wilson Sonsini Goodrich & Rosati
$32	Subscribers Preview	2002	Administrative Services, Financial Management and Office Sharing Agreement [Amended and Restated]	Helix BioMedix, Inc.
$40	Subscribers	2004	Advanced Magnetics Submits Response To FDA Approvable Letter for Combidex(R)	Advanced Magnetics, Inc.	Cytogen Corp.
$47	Subscribers Preview	2007	Affiliation Agreement	Tercica, Inc.